top of page
Publications
[136] A First-In-Human Phase 1 Study to Evaluate the Safety and Tolerability of LEM-S401, a Novel siRNA-DegradaBALL Drug Targeting CTGF in Healthy Adults
Ha-Yeon Kim, Jaeso Cho, Min Kyu Park, Dal-Hee Min*, Jun Gi Hwang*, and Cheolhee Won*, CTS-Clin. Transl. Sci. 2025, 18(4), e70207 (Published date : 31 May 2025)